Total Payments
$18,029
2024 Payments
$578.26
Companies
42
Transactions
784
Medicare Patients
257
Medicare Billing
$29,691
Payment Breakdown by Category
Food & Beverage$17,404 (96.5%)
Education$439.76 (2.4%)
Travel$185.42 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,404 | 772 | 96.5% |
| Education | $439.76 | 11 | 2.4% |
| Travel and Lodging | $185.42 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,244 | 172 | $0 (2024) |
| Janssen Biotech, Inc. | $1,715 | 81 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,428 | 63 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,352 | 82 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $792.21 | 42 | $0 (2023) |
| Celgene Corporation | $772.85 | 32 | $0 (2023) |
| Gilead Sciences, Inc. | $694.08 | 24 | $0 (2021) |
| INTERCEPT PHARMACEUTICALS, INC. | $613.43 | 22 | $0 (2023) |
| Prometheus Laboratories Inc. | $548.72 | 29 | $0 (2018) |
| PFIZER INC. | $518.55 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $578.26 | 10 | Lilly USA, LLC ($187.92) |
| 2023 | $2,531 | 74 | AbbVie Inc. ($798.85) |
| 2022 | $3,234 | 119 | ABBVIE INC. ($903.88) |
| 2021 | $2,208 | 105 | AbbVie Inc. ($518.16) |
| 2020 | $1,126 | 64 | AbbVie Inc. ($299.14) |
| 2019 | $2,759 | 138 | AbbVie, Inc. ($585.85) |
| 2018 | $3,046 | 147 | AbbVie, Inc. ($433.75) |
| 2017 | $2,547 | 127 | AbbVie, Inc. ($612.13) |
All Payment Transactions
784 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.30 | General |
| 10/31/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $42.04 | General |
| Category: LIVER DISEASE | ||||||
| 10/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $85.78 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.15 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/24/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Obesity | ||||||
| 06/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Immunology | ||||||
| 05/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | Cash or cash equivalent | $121.88 | General |
| Category: Immunology | ||||||
| 05/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $92.50 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $110.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/05/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Immunology | ||||||
| 10/24/2023 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $35.89 | General |
| Category: GI | ||||||
| 10/23/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $56.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $102.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/20/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: Neuroscience | ||||||
| 09/15/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: VIROLOGY | ||||||
| 08/31/2023 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $38.14 | General |
| Category: GI | ||||||
| 08/30/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $103.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Gastroenterology | ||||||
| 07/29/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Immunology | ||||||
| 07/27/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $35.71 | General |
| Category: Immunology | ||||||
| 07/26/2023 | NESTLE HEALTHCARE NUTRITION INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: GI | ||||||
| 07/24/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/19/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/18/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 52 | 52 | $14,493 | $5,864 |
| 2022 | 3 | 68 | 77 | $14,894 | $9,121 |
| 2021 | 4 | 81 | 83 | $18,627 | $9,334 |
| 2020 | 3 | 56 | 61 | $10,811 | $5,372 |
Total Patients
257
Total Services
273
Medicare Billing
$29,691
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 14 | 14 | $5,531 | $2,925 | 52.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $1,822 | $1,068 | 58.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $5,549 | $948.01 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 16 | $1,591 | $922.59 | 58.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 20 | $7,902 | $4,026 | 51.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $3,312 | $2,613 | 78.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 37 | $3,680 | $2,482 | 67.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 31 | 31 | $12,248 | $6,310 | 51.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 14 | $1,392 | $1,114 | 80.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 12 | 13 | $2,486 | $1,045 | 42.0% |
| 99423 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes | Office | 2021 | 24 | 25 | $2,500 | $866.08 | 34.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 16 | 16 | $6,322 | $3,344 | 52.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 19 | $1,890 | $1,032 | 54.6% |
| 99423 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes | Office | 2020 | 23 | 26 | $2,600 | $995.10 | 38.3% |
About Dr. Samuel Sim, MD
Dr. Samuel Sim, MD is a Gastroenterology healthcare provider based in Bristol, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275633844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Sim, MD has received a total of $18,029 in payments from pharmaceutical and medical device companies, with $578.26 received in 2024. These payments were reported across 784 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($17,404).
As a Medicare-enrolled provider, Sim has provided services to 257 Medicare beneficiaries, totaling 273 services with total Medicare billing of $29,691. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Bristol, TN
- Active Since 09/24/2006
- Last Updated 07/07/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1275633844
Products in Payments
- STELARA (Biological) $1,850
- XIFAXAN (Drug) $1,164
- ZEPOSIA (Drug) $957.36
- RINVOQ (Biological) $849.67
- ZENPEP (Drug) $795.60
- Humira (Biological) $707.65
- ENTYVIO (Biological) $688.80
- LINX Reflux Management System (Device) $633.34
- SKYRIZI (Biological) $621.97
- OCALIVA (Drug) $613.43
- HUMIRA (Biological) $512.88
- INJECTAFER (Drug) $429.48
- XELJANZ (Drug) $426.96
- LINZESS (Drug) $381.91
- Creon (Drug) $313.84
- MAVYRET (Drug) $276.58
- DUPIXENT (Biological) $252.10
- Mavyret (Drug) $248.16
- VIBERZI (Drug) $241.51
- Cimzia (Drug) $240.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bristol
Salam Zakko, Md, MD
Gastroenterology — Payments: $84,753
Gastroenterology $84,753
Dr. Peter Bloom, M.d, M.D
Gastroenterology — Payments: $10,834
Gastroenterology $10,834
Daniel Smiley, Md, MD
Gastroenterology — Payments: $9,620
Gastroenterology $9,620
Dr. Joshua Hall, M.d, M.D
Gastroenterology — Payments: $5,824
Gastroenterology $5,824
Dr. Garieann Fish, D.o, D.O
Gastroenterology — Payments: $4,286
Gastroenterology $4,286
Dr. Joanna Sampson, M.d, M.D
Gastroenterology — Payments: $3,713
Gastroenterology $3,713